Principal Pharmaceutical Analyst (Sample Management)

LIKELY QUESTIONS

- How have you developed, reviewed, and implemented sample management SOPs in a pharmaceutical quality control laboratory?
- Describe your experience ensuring compliance with WHO good practices for Pharmaceutical Quality Control Laboratories and ISO 17025 in sample receipt, storage, and tracking.
- What controls would you put in place to ensure end-to-end sample traceability from receipt through testing, retention, and disposal?
- How have you used a LIMS to protect sample data integrity, control access, manage audit trails, and prevent loss or mix-up of samples?
- Walk us through how you would assess an incoming sample consignment that has incomplete documentation, damaged packaging, or temperature excursion concerns.
- How do you verify that quotations, invoices, requests for analysis, and methods of analysis accurately match the laboratory work performed?
- What environmental conditions are critical in a sample management area, and how would you respond to a documented excursion?
- How would you contribute to work planning, budgeting, procurement forecasting, and performance management for a sample management department?

BEHAVIOURAL QUESTIONS

- Tell us about a time you identified a gap in a laboratory procedure and improved it.
Model approach: Situation: A sample receipt process relied on inconsistent manual checks and created delays or documentation errors. Task: Strengthen compliance, traceability, and turnaround time. Action: Reviewed deviations and user feedback, mapped the process, updated the SOP and forms, consulted quality and laboratory teams, trained staff, and monitored implementation through KPIs and internal audits. Result: Reduced errors and turnaround time, improved inspection readiness, and achieved consistent procedure adoption.

- Describe a time you managed a sample integrity or chain-of-custody issue.
Model approach: Situation: A sample arrived with a discrepancy such as missing documentation, damaged packaging, incorrect labeling, or a temperature concern. Task: Protect sample integrity while ensuring an appropriate and timely decision. Action: Quarantined the sample, documented the issue in the LIMS, notified the client and relevant quality personnel, assessed the impact against procedures, obtained clarification or authorization, and implemented corrective actions. Result: Prevented use of a potentially unsuitable sample, preserved a complete audit trail, and improved receiving controls to prevent recurrence.

- Give an example of when you had to balance competing laboratory priorities and limited resources.
Model approach: Situation: Multiple urgent consignments, routine testing demands, and constrained staffing or storage capacity created operational pressure. Task: Maintain compliance and meet service commitments without compromising quality. Action: Risk-ranked samples by regulatory, stability, safety, and client priority; allocated staff and storage; communicated realistic timelines; tracked progress in the LIMS; and escalated resource needs with supporting data. Result: Priority work was completed on time, no sample integrity failures occurred, and management received a practical resource or procurement plan.

- Tell us about a time you handled resistance to a new system, SOP, or compliance requirement.
Model approach: Situation: Staff were hesitant to adopt a revised SOP, LIMS workflow, or documentation control process. Task: Achieve sustained compliance while maintaining operational continuity. Action: Explained the quality and regulatory rationale, involved users in practical testing, simplified job aids, delivered targeted coaching, reviewed early errors constructively, and used audit findings and metrics to reinforce expectations. Result: Adoption improved, deviations decreased, and the team demonstrated stronger ownership of quality practices.

SMART QUESTIONS TO ASK

- What are the most significant sample management risks or audit findings the laboratory is currently working to address?
- How mature is the current LIMS, and what improvements are planned for sample lifecycle management, audit trails, reporting, and data security?
- What sample types, client categories, and testing priorities generate the highest volume or greatest operational complexity for this department?
- How will success in this role be measured during the first six months and over the two-year contract period?
- What level of authority will the Principal Pharmaceutical Analyst have to revise procedures, initiate CAPAs, and recommend resource or procurement priorities?

RED FLAGS TO WATCH FOR

- Unclear answers about LIMS validation, data backups, user-access controls, audit trails, or how sample traceability is maintained during system downtime.
- A culture that treats sample receipt, storage conditions, deviations, or documentation as administrative tasks rather than critical quality-system controls.
- Persistent resource gaps such as inadequate controlled storage, calibration support, staffing, PPE, disposal capacity, or budget, with no credible mitigation plan.